HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Mollee Selected Research

Dexamethasone (Maxidex)

1/2024Carfilzomib, thalidomide, and dexamethasone is safe and effective in relapsed and/or refractory multiple myeloma: final report of the single arm, multicenter phase II ALLG MM018/AMN002 study.
1/2022Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study.
1/2022Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14).
1/2021Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
10/2020Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis.
1/2011Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: results from an Australian population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Mollee Research Topics

Disease

12Multiple Myeloma
01/2024 - 08/2009
12Immunoglobulin Light-chain Amyloidosis
11/2023 - 08/2009
8Neoplasms (Cancer)
11/2023 - 09/2006
7Lymphoma (Lymphomas)
01/2024 - 02/2005
7Lymphoproliferative Disorders (Lymphoproliferative Disorder)
11/2021 - 02/2007
6Amyloidosis
12/2022 - 01/2016
5B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2023 - 10/2013
5Disease Progression
01/2020 - 02/2012
4Paraproteinemias (Monoclonal Gammopathy)
11/2023 - 08/2009
4Infections
01/2023 - 10/2002
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2018 - 03/2008
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2021 - 10/2002
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2021 - 10/2019
2Pneumonia (Pneumonitis)
01/2021 - 01/2020
2Thrombotic Microangiopathies
01/2019 - 04/2015
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2018 - 10/2002
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018 - 03/2003
2Kidney Diseases (Kidney Disease)
11/2017 - 06/2016
2Hemolysis
02/2017 - 12/2005
2Thrombocytopenia (Thrombopenia)
06/2013 - 03/2012
2Hodgkin Disease (Hodgkin's Disease)
02/2006 - 01/2006
1Peripheral Nervous System Diseases (PNS Diseases)
05/2024
1Monoclonal Gammopathy of Undetermined Significance
11/2023
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2023
1Human Influenza (Influenza)
01/2023
1Frailty
01/2023
1Melanoma (Melanoma, Malignant)
01/2023
1Latent Infection
01/2023
1Heart Diseases (Heart Disease)
01/2022
1Fatigue
01/2022
1Pain (Aches)
01/2022
1Pathologic Complete Response
11/2021
1Hemorrhage
04/2021
1Diarrhea
01/2021
1Heart Failure
01/2021
1Lymphopenia (Lymphocytopenia)
01/2021
1Cardiomyopathies (Cardiomyopathy)
01/2021
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2021
1Thrombosis (Thrombus)
12/2020
1Fever (Fevers)
01/2020
1COVID-19
01/2020
1Lung Neoplasms (Lung Cancer)
01/2020
1Communicable Diseases (Infectious Diseases)
01/2020
1Transfusion Reaction
01/2018
1Bone Diseases (Bone Disease)
08/2017
1Sepsis (Septicemia)
01/2017
1Chronic Kidney Failure (Chronic Renal Failure)
06/2016

Drug/Important Bio-Agent (IBA)

6Dexamethasone (Maxidex)FDA LinkGeneric
01/2024 - 01/2011
6Bortezomib (Velcade)FDA Link
12/2022 - 02/2017
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 10/2002
6Rituximab (Mabthera)FDA Link
12/2021 - 10/2002
5Proteins (Proteins, Gene)FDA Link
11/2023 - 08/2009
5daratumumabIBA
12/2022 - 01/2018
4Amyloid (Amyloid Fibrils)IBA
11/2023 - 11/2017
4Immunoglobulins (Immunoglobulin)IBA
11/2023 - 06/2016
4Vincristine (Oncovin)FDA LinkGeneric
11/2021 - 10/2002
4ParaproteinsIBA
01/2019 - 08/2009
3Monoclonal AntibodiesIBA
12/2022 - 12/2013
3Melphalan (Alkeran)FDA LinkGeneric
03/2022 - 06/2012
3Doxorubicin (Adriamycin)FDA LinkGeneric
11/2021 - 01/2011
3AntibodiesIBA
01/2020 - 06/2013
3Cytarabine (Cytosar-U)FDA LinkGeneric
12/2018 - 01/2011
2carfilzomibIBA
01/2024 - 01/2022
2Thalidomide (Thalomid)FDA Link
01/2024 - 02/2006
2Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
12/2022 - 01/2021
2Lenalidomide (CC 5013)FDA Link
01/2022 - 08/2017
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2006
2LipidsIBA
01/2020 - 12/2005
2Prednisone (Sone)FDA LinkGeneric
02/2017 - 10/2002
2LatexIBA
06/2016 - 12/2013
2Heparin (Liquaemin)FDA LinkGeneric
06/2013 - 03/2012
2DNA (Deoxyribonucleic Acid)IBA
01/2006 - 10/2002
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2023
1Immune Checkpoint InhibitorsIBA
01/2023
1ibrutinibIBA
01/2023
1Prealbumin (Transthyretin)IBA
12/2022
1Technetium (Technetium 99m)IBA
12/2022
1Serum AlbuminIBA
01/2022
1pomalidomideIBA
01/2022
1Prednisolone (Predate)FDA LinkGeneric
11/2021
1Factor X (Stuart Factor)IBA
04/2021
1LigandsIBA
12/2019
1fludarabineIBA
10/2019
1Brain Natriuretic Peptide (Natrecor)FDA Link
09/2019
1pro-brain natriuretic peptide (1-76)IBA
09/2019
1AntimetabolitesIBA
11/2018
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2018
1Calcineurin InhibitorsIBA
11/2018
1Diphosphonates (Bisphosphonates)IBA
08/2017
1Immunoglobulin M (IgM)IBA
01/2017

Therapy/Procedure

17Therapeutics
05/2024 - 02/2005
10Drug Therapy (Chemotherapy)
03/2022 - 03/2003
4Stem Cell Transplantation
03/2022 - 02/2005
3Catheters
01/2021 - 01/2017
3Transplantation
02/2012 - 08/2009
2Radiotherapy
12/2021 - 10/2002
2Combined Modality Therapy
12/2021 - 10/2019
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2020
1Palliative Care (Palliative Therapy)
01/2020
1Plasmapheresis
02/2017